Most domain portfolios are mispriced because they are guessed at. The market has comp-sales data, but the data is fragmented across marketplaces, broker disclosures, and private transactions. Pulling it together into a defensible number per domain takes a regression model plus the operator judgment that anchors what the model produces.
We value every domain in your portfolio using comp-sales regression, semantic similarity to recent sales, and LLM-judged brandability, with confidence intervals so you know which numbers to trust and which to flag for operator review.
What you receive
- Per-domain valuation with point estimate and confidence interval
- Comp-sales basis showing the comparable transactions that anchor the estimate
- Brandability score from an LLM rationale tied to semantic and phonetic factors
- Portfolio-level summary with concentration analysis and risk flags
- Diligence-ready report in PDF for M&A or finance counterparties
When this product earns its place
Quarterly portfolio reviews. M&A diligence (buy-side or sell-side). Insurance and asset-class valuation. Internal capital allocation decisions about renewal versus drop. Pre-listing pricing for active sell-side brokerage.
Buyer pain we address
- Internal valuations are guesses with no defensible basis
- Broker valuations are biased by commission incentives
- M&A diligence demands a defensible number with confidence intervals, not a single point estimate